SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mama Bear who wrote (2156)1/30/1998 1:51:00 AM
From: Dr. Voodoo  Read Replies (1) of 7041
 
Question to all,

If I interpret Dr. Imhof's 1975 data to imply that the tablets he used were rapidly absorbed for one reason or another. And that Grant Gwinup publicly disclosed oral phentolamine as treatment for ED. Do these two items taken together constitute prior art? Restated more clearly, Zonagen would have known from reading the literature, that other people's public disclosure of prior art and invention, demonstrated a)oral phentolamine led to a statistically beneficial treatment of ED. and b) that Phentolamine by itself was rapidly absorbed into the bloodstream by the gut.

I'm hounding this patent question because nobody wants to answer it directly except TA and he thinks this is all a hoax. If this is so, I really don't see how they can market their pills unless SGP is the manufacturer, and they will have to compete with generic drug companies who can market the exact same formulation because their patent claims would not be allowed because the formulation is too obvious. Would someone PLEASE comment?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News